Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine.
D000328:Adult; D001835:Body Weight; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D002936:Cinnarizine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005444:Flunarizine; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D010918:Pizotyline / Q000009:adverse effects / Q000627:therapeutic use*; D011897:Random Allocation; D013876:Thiophenes / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D013876:Thiophenes; D010918:Pizotyline; D002936:Cinnarizine; D005444:Flunarizine